INSIGHT -- Aspect Newsletter -- Fall 2002
In This Issue:
Clinical Perspective
Interview with Doctor Gilles Fraser (pharmacologist)
Interview with Doctor Lewis Kaplan (surgeon)
ITHE COALITION FOR CRITICAL CARE EXCELLENCE
The coalition is a determined effort to bring together the best minds in critical care to develop innovative solutions that will benefit critically ill patients, says Patricia McGaffigan, MS, RN
WEBCASTS FOR FIRST HALF OF 2003
Mark your calendars now to participate in our ongoing eLearning Webcast Series
TRADESHOWS FOR FIRST HALF OF 2003
Contact Us

Interview with Doctor Lewis Kaplan (surgeon)

Doctor Lewis Kaplan (surgeon)

A Surgeon discusses his experiences using BIS

Dr. Lewis Kaplan is Associate Professor of Surgery and Director, Emergency General Surgery Section of Trauma and Critical Care at Yale University School of Medicine. Prior to coming to Yale, Dr. Kaplan was Associate Professor of Surgery in the Division of Trauma and Surgical Critical Care at the Medical College of Pennsylvania-Hahnemann University.

Aspect:  You believe Aspect's BIS monitor is a valuable tool in the ICU, but you weren't convinced at first. Why were you skeptical?
LK:  I was a clinical fellow when I first encountered the BIS in the ICU. My skepticism was that the BIS is a form of processed EEG. EEGs are completely uninterpretable by the average physician - you need a neurologist - so translating the EEG into an objective sedation scale seemed to me far-fetched.

Aspect:  What observations led you to the conclusion that BIS monitoring had clinical value in the ICU?
LK:  Over the course of a couple of months, as I observed patients who were paralyzed and sedated, I noticed that as we would lighten their sedation the BIS value would rise. The correlation between BIS values and what I observed clinically convinced me that this was more than just artifact. There was a close correlation between the BIS value and patient status.

Aspect:  In what types of ICU cases do you find the BIS monitor most useful?
LK:  All patients who receive paralytic sedation should have the monitor as a standard because there is no other tool for assessing their sedation level. We find that BIS is also very useful in patients maintained on sedative infusions so we can accurately evaluate how deep they are and avoid oversedation. A third group for whom we find BIS very valuable is patients maintained on continuous infusions of sedatives and analgesics as part of a post-operative regimen. We don't want them heavily sedated, but we also don't want them roaming all over the bed. In those cases we want to assure they're at an acceptable sedation level where they're controllable, and not so heavily sedated that it takes days to wake them up.

Aspect:  Any others?
LK:  Yes. BIS is very useful for patients in a drug-induced coma, such as with pentobarbital or propofol. The goal is to maintain a burst-suppression EEG pattern. Before the BIS this could be quite complicated, as it often required getting an EEG monitor & technician and a neurologist. There were also prolonged gaps when we had no data due to the need to transport the patient out of the ICU for other tests such as a CT scan of the brain. And after a CT scan, the EEG leads need to be reapplied. The BIS monitor, on the other hand, is compact, takes up very little space, and there's only one sensor that's easily applied. Average clinicians are able to easily interpret the patient's response to treatment and can titrate sedatives to the BIS value and suppression ratio recommended by the neurology team. You don't need the EEG technician to operate the BIS, and you may not need as many visits from the neurologist. Further, there's a clinical benefit to the continuous availability of data, which enables clinicians to evaluate and titrate to maintain a consistent burst suppression pattern.

Aspect:  How big a problem is oversedation in the ICU?
LK:  Consistency of sedation is a problem in the ICU. To make sure the patient is comfortable we tend to err on the side of too much rather than too little sedation. When patients receive more sedation than is necessary, they become more difficult to assess and manage. Our data, published in Critical Care 2000, revealed that more than 69% of paralyzed patients on sedative infusions were found to be inappropriately sedated. The majority, or 54%, were oversedated.

Aspect:  What are some of the consequences of oversedation?
LK:  It's not uncommon to embark on a neurologic work-up consisting of additional labs, perhaps an additional CT-scan, and a neurologic consultation, all as a result of oversedation. Some patients develop an acidosis from the vehicle in which some of the sedatives are mixed. Oversedated patients are unable to participate in their care, are weaker, and stay on the ventilator longer. They may not be able to change position in bed so they can develop pressure ulcerations, and they are at risk for infections, including ventilator-associated pneumonia. Oversedated patients also have longer ICU stays and longer hospital stays, all of which means increased costs and use of precious resources. Those patients who have been on paralytics may develop a prolonged neuromuscular blockade syndrome even after the agent is withdrawn. You also need to consider the high cost of sedative drugs when patients are oversedated. In our study, we were able to achieve an 18% decrease in the cost of sedative drugs for an average of $150 per patient by adding BIS monitoring to assess and titrate sedatives.

Aspect:  Undersedation also has its costs and risks.
LK:  Yes. If a patient has acute respiratory distress syndrome and you leave them undersedated, they may become agitated and might pull out the endotracheal tube and get hypoxic. Unintended medical device removal has implications involving cost, nursing resources and patient outcomes. There are also the consequences of recall of unpleasant experiences. In our study, we achieved a 78% reduction in patient recall of unpleasant experiences in paralyzed patients when sedatives were titrated to BIS values rather than hemodynamic parameters.

Aspect:  What is the role of BIS, then, in trying to achieve the right balance in each patient?
LK:  The right balance is patient-dependent and will change over time throughout the course of their care and as their goals for care change. One of the ways we determine whether a patient is adequately sedated is by following both baseline and stimulated BIS values. In other words, we assess what happens to the BIS value when the patient is suctioned, or a tube is manipulated, when they are rolled over for their bath, or their fractured extremity is moved. As long as we maintain adequate analgesia, they're not so deep that I have to worry about over-medication, but not so light that talking around them or suctioning them is going to provoke them to a BIS value in the 90s where they might pull their tube out. BIS gives you an objective measure to titrate sedatives to a physiologically defined endpoint, as compared to a subjective idea of how much medication a patient should receive. It also allows us to better manage the balance between sedation and analgesia. With BIS, we've been able to cut across very different training backgrounds, different perspectives and different biases, and achieve some parity in care across shifts. BIS provides an easy-to-follow common point of reference.

Aspect:  Given your familiarity with the BIS monitor, what other possible applications do you think it has?
LK:  For many conscious sedation procedures there hasn't been a good way of evaluating how deeply sedated a patient has become. From a safety and medical error perspective, incorporating BIS into moderate or conscious sedation protocols would seem to make it safer for the patient and help caregivers achieve the results they are looking for: a calm, co-operative patient that isn't oversedated and maintains their airway. BIS seems to be an intelligent way of handling some of the concerns the Joint Commission has articulated while ensuring quality care and avoiding what is an area of intense scrutiny: avoidable medical errors. BIS can have a huge impact in this regard. There may also be future value in the use of BIS on patients who enter the emergency department with altered levels of consciousness. There are certainly numerous avenues to explore.

In our study, we were able to achieve an 18% decrease in the cost of sedative drugs for an average of $150 per patient by adding BIS monitoring to assess and titrate sedatives.

Back to Top | Home     

 

View Archived Newsletters

Home | Signup | Feedback or Comments
© Copyright 2003 Aspect Medical Systems. All Rights Reserved

Aspect Medical Systems